Cite
Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies.
MLA
French, Rr, et al. “Delivery of the Ribosome-Inactivating Protein, Gelonin, to Lymphoma Cells via CD22 and CD38 Using Bispecific Antibodies.” British Journal of Cancer, vol. 71, no. 5, May 1995, pp. 986–94. EBSCOhost, https://doi.org/10.1038/bjc.1995.190.
APA
French, R., Penney, C., Browning, A., Stirpe, F., George, A., Glennie, M., French, R. R., Penney, C. A., Browning, A. C., George, A. J., & Glennie, M. J. (1995). Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies. British Journal of Cancer, 71(5), 986–994. https://doi.org/10.1038/bjc.1995.190
Chicago
French, Rr, Ca Penney, Ac Browning, F Stirpe, Ajt George, Mj Glennie, R R French, et al. 1995. “Delivery of the Ribosome-Inactivating Protein, Gelonin, to Lymphoma Cells via CD22 and CD38 Using Bispecific Antibodies.” British Journal of Cancer 71 (5): 986–94. doi:10.1038/bjc.1995.190.